R&D Changing Faces: Board of Director and Advisory Board hires, ... September’s boardroom moves brought seasoned pharma executives, investors, and scientific leaders into new governance and advisory roles across the life sciences sector.
R&D Changing Faces: Board of Director and Advisory Board hires, ... Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August.
R&D Changing Faces: Board appointments, June and July 2026 Board appointments June/July brought together veterans from across the pharmaceutical industry, venture capital, healthcare technology, and academia
Market Access Changing Faces: Boards of Directors and Advisory Boards, May... The latest Board moves reflect a focus on experience in commercialisation, corporate governance, and therapeutic development.
R&D Changing Faces: Boards of Directors and Advisory Boards – Ap... Boardrooms and advisory panels across biotech, pharma, digital health, and life sciences suppliers saw a wave of high‑profile additions in April.
R&D Changing Faces: Board of Directors and Advisory Boards, Marc... Board‑level appointments this month were thick and fast, with six Boards adding new faces as Chairperson.
News Angelini Pharma's R&D chief heads for the exit Dr Rafal Kaminski's near five-year tenure as chief scientific officer of Italy's Angelini Pharma will come to an end in the next couple of weeks.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.